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The distribution of cell types and synapses is well characterized in the rodent 
olfactory bulb (OB), and from that plausible models of odor processing have been 
constructed.  Individual olfactory sensory neurons (OSNs) express only 1 of ~1000 
odorant receptors (ORs) and send their axons to specific synaptic targets in the OB 
glomerular neuropil.  Each glomerulus is innervated exclusively by OSN axons 
expressing the same OR.  The distribution of these glomeruli is conserved across animals, 
as is the numerical relationship between number of expressed ORs and number of 
glomeruli in the OB.  Our objective is to extend such results to the level of the human OB 
to determine how its cellular and synaptic organization, and more specifically how the 
number and distribution of its glomeruli, compare to what has been elucidated in mice.  
As there are ~2,000 glomeruli for ~1,000 ORs in mice, we predicted ~700 glomeruli in 
humans based on the ~350 intact OR genes identified in the human through genomic 
studies.  Using immunohistochemistry, the organization of cells and synapses in human 
OBs was evaluated and quantified.  While the laminar structure of the OB is broadly 
conserved between species, in the human OB the laminar organization as well as 
additional structural features suggest a less rigorously organized OB than in rodents, 
perhaps suggesting that odor processing in the human OB may be less efficient than in 
mice.  Of particular note, the total number of glomeruli in the human OB differs 
significantly from predicted and demonstrates a high degree of variability amongst 
specimens, thus far ranging from approximately 3000 - 9000/OB.  These results indicate 
that the principles of OR-homotypic axon convergence developed from mouse studies 
may not be readily applicable to the human, and that central processing of odor signals in 
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Odors are detected by a complicated chemical sensing system that is conserved 
across many organisms. 
 Organisms use their sense of smell to detect their chemical environment, which is 
a crucial function for survival.  At the most fundamental level, even single-celled 
organisms are able to detect and respond to chemicals in their surroundings.  The ability 
to smell plays a key role in higher organisms that rely on olfaction for processes such as 
detecting food, staying away from poisonous substances, finding mates, and avoiding 
predators.  While olfaction is the primary modality in many organisms for these survival 
behaviors, other organisms, such as humans, have grown to rely more heavily on their 
other senses for these same behaviors.  
  Despite the large variation in the degree to which different organisms depend on 
olfaction, the organization of this system appears to be broadly conserved across species.  
Comparisons have been done between species to evaluate for similarities in several 
aspects of the olfactory pathway including: receptor genes and receptor gene expression, 
odorant-binding-induced signal transduction, and even certain components of central 
organization and neural processing (1-3).  The species examined ranged from Drosophila 
melanogaster (fruit fly) in the arthropod phylum to Rana spp. (frog), Carassius aruatus 
(goldfish), Mus musculus clomesticus (mouse), and Homo sapiens (human) in the 
vertebrate phylum.  These studies broadly demonstrated striking similarities at these 




likely stems from a combination of homology, or inheritance from common ancestors, as 
well as convergence, or adaptation to the most efficient and functional solution to 
common environmental demands.  There are several species in which there have been 
extensive studies of the olfactory system in order to gain an understanding of odor 
processing, including Drosophila, rats, and mice.  Because they are mammals, most of 
the assumptions about the organization of the human olfactory system are based on 
rodent studies. 
 The unique complexity of the olfactory system is demonstrated superficially by 
the relatively large number of different receptors that are used to detect odor input as 
compared to the other senses that organisms use to perceive their environment.  Sound is 
detected by hair cells in the cochlea, which allow for pitch discrimination based on the 
topography of cells activated by different frequencies of sound waves.  The receptor cells 
for vision are composed of rods and cones which detect light.  The topography of the 
cells on the retina when receptors are activated by light allow organisms to perceive 
distinct images.  Somatosensory detection also occurs through only a few types of 
receptors; mechanoreceptors detect light pressure, nociceptors detect strong pressure, and 
thermoreceptors detect heat, all providing the body with information about its physical 
surroundings.  Taste, the other chemical sense, is the only other sense that relies on more 
than just a few different types of receptors to detect input stimuli, in this case tastants.  
However, even taste receptors cannot compare in sheer number to odorant receptors; for 
example mice are thought to have ~36 taste receptors (4), while they have ~1000 odorant 
receptors (5-7).  Because of the large numbers of inputs, mapping and understanding the 




odor processing is of utmost importance for learning how the olfactory system works.  
Perhaps because of this organizational complexity, gaining an understanding of the 
olfactory system has lagged behind other sensory systems.   Major gains in this area have 
occurred primarily in the last 10-15 years after the identification of the family of 
receptors responsible for detecting odorants. 
  
Odor processing begins at the level of the odorant receptors, which are represented 
genetically by a large and diverse group of genes. 
 Mammalian odorant receptor (OR) genes comprise the largest identified family of 
genes.  They were first described in rats by Dr. Linda Buck and Dr. Richard Axel in 1991 
(8).  Buck and Axel’s original investigations were based on several novel and innovative 
initial assumptions regarding the genetic, biochemical, and cellular characteristics of the 
olfactory system.  First, that the ORs were likely G-protein-coupled receptors, for which 
there was preliminary biochemical evidence, and would therefore likely be seven-
transmembrane proteins.  Second, they predicted that ORs would comprise a large family 
of genes due to the large number and complexity of chemicals that organisms must be 
able to detect and discriminate.  Finally, they believed that ORs would likely be 
expressed selectively in OSNs.  Their assumptions proved to be correct, and their 
successful discovery of OR genes earned them the Nobel Prize in Medicine and 
Physiology in 2004.  It also pioneered future studies that have led to an understanding of 
odor processing and the organization of the olfactory system in mice and rats.     
 As described by Buck and Axel, ORs are G-protein-coupled receptors with a 




introns.  There are several conserved motifs that identify genes as ORs, while the 
transmembrane domains 3, 4, and 5 are hypervariable, and could likely represent areas 
that come together to form the odorant binding pocket (9).  Signaling occurs via a G-
protein/cAMP pathway after binding of an odorant, resulting in depolarization and an 
increase in spiking frequency.  Interestingly, this cAMP pathway has also been shown to 
play a role in axonal targeting by OSN during the wiring of the olfactory system (10). 
After the discovery of the family of OR receptors in rats, work went underway to 
identify these genes in other vertebrates.  Most of this work used the technique of PCR 
amplification with degenerate oligonucleotide primers for conserved motifs (11), work 
which was facilitated by the ability to use genomic DNA instead of cDNA, as the coding 
region of OR genes is intronless.  Over a dozen species were selected for study (12, 13), 
and confirmation of the presence of OR genes was successful in all.  However, it was 
unknown exactly how big this family of genes was, as these studies by no means were 
exhaustive in identifying OR genes in any given species.  Estimates of the complexity of 
the OR family in rats ranged from 200 (8) to 500-1000 (14). 
Comprehensive genomic mining studies to identify the large family of OR genes 
in mice was first undertaken in 2002 after the release of the Celera mouse genome in 
2000 (5, 15).  These groups identified ~1300 OR genes, with only ~80% of these, or 
~1000 genes, containing intact open reading frames.   The remaining ~20% are 
pseudogenes, containing disruptions in the coding region including insertions, deletion, 
frame shifts, and premature stop codons.  OR genes were found on all 20 pairs of 
chromosomes in the mouse except for 12 and Y.  Most OR genes occur in clusters, 




clusters in mice containing 87% of the ORs, with the remaining 13% occurring singly or 
in smaller groups throughout the genome.   
Due to the high degree of similarity amongst genes that are clustered together, 
Zhang and Firestein (5) hypothesized that local sequence duplication was a likely 
mechanism contributing to OR family expansion.  They also noted that many of the OR 
gene clusters contain non-OR genes.  In 15 out of 27 clusters, these genes encoded 
retrovirus related Gag proteins, and the density of these genes is twice as high in OR 
clusters as in the rest of the genome.  This data, combined with the fact that OR genes are 
intronless, has led to the theory that duplication of the OR family may be retrovirus-
mediated (16, 17). 
This sequencing of genomes from many different organisms within the last 
several years has allowed for efficient mining of OR genes across multiple species.  The 
first draft of the human genome sequence became available in 2001 by Celera Genomics 
(18) and the International Human Genome Project Consortium (19). Several groups have 
used this data to fully identify the large family of human ORs.  A first analysis was done 
by the Weizmann Institute (20, 21), where they found 322 OR genes with intact open 
reading frames.  A second study was performed by the Senomyx group (22) who found 
347 candidate human OR genes with intact open reading frames.  While, by first analysis, 
the human genome appears to have ~1000 OR genes, about 60% of these are 
pseudogenes with fatal errors in their coding region.  This is a much higher percentage of 
pseudogenes than the 20% that has been identified both in mice (5) and rats (23), likely 
representing humans’ decreased dependence on olfaction for survival over evolution 




The average human OR is 315 amino acids long, with about a dozen conserved 
sequence motifs defining these sequences as OR genes.  These ~350 genes represent 1% 
if the putative 30,000 genes in the human genome, as well as 1% of the 30 Mb length of 
genomic DNA.  They are found on all chromosomes except for chromosome 22 and the 
Y chromosome.  As in mice, while some genes are located singly throughout the genome, 
80% are embedded within 24 larger clusters spread throughout the different 
chromosomes, and 42% are found in clusters on chromosome 11.   
Sequence similarities between OR clusters in humans and mice has allowed for 
the identification of potentially orthologous OR gene clusters.  The cluster at human 
chromosome 17p13.3 and mouse chromosome 11B3-11B5 (24) shares a high degree of 
homology and likely represents a common evolutionary derivative.  Additional studies 
have further proven the high degree of homology between human and mouse ORs (25-
28), representing further justification for the utilization of rodent olfaction as a model for 
human olfaction.  However, due to genomic changes in both humans and mice since the 
rodent-primate divergence, it is impossible to identify one-to-one orthologous 
relationships for most OR genes.  In mice, local duplications have dominated the 
differences seen between species, while in humans, deletions and interchromosomal 
duplications dominate, resulting in larger OR gene clusters in mice and smaller, more 
distributed clusters or single genes in humans.  Young et al. (29) argues that this 
represents different evolutionary forces shaping OR gene families in humans and mice, 
which complicates the often accepted assumptions of common OR-ligand relationships 




OR proteins are expressed highly in the cilia of OSN dendrites.  These cilia 
project from dendrites into the mucus layer of the olfactory epithelium, located in the 
posterior nasal cavity of mammals.  This mucus layer is where the signal-receptor 
interaction takes place between odorants dissolved in the mucus and ORs that are found 
on the surface of cilia.  The transcription of OR genes in these OSNs is a highly regulated 
process, with any single OR gene only being expressed in a subset of OSNs.  
Furthermore, single-cell RT-PCR data has shown that any given OSN only expresses a 
single OR (30-32).  This idea is the basis for the one receptor-one neuron hypothesis, in 
which only one out of ~1000 genes in the OR family repertoire is selected for expression 
in an OSN.  In addition, RT-PCR looking at pools of OSNs with polymorphic OR alleles 
has demonstrated that expression of ORs is monoallelic (33), a conclusion that has been 
confirmed by several subsequent studies (34, 35).  Both maternal and paternal alleles are 
expressed in separate OSNs in approximately equal numbers.   
The genetic regulation of this OR gene selection process is not well understood, 
though in mouse and rats it has been shown that expression of any single OR only occurs 
in one of four parallel zones in the olfactory epithelium (36-38).  Within each zone, 
expression of ORs appears to be completely random.  While the presence of zones has 
been described for over a decade, the functional role it plays in odor processing is still 
unclear. 
 
The olfactory bulb coordinates sensory input on its way to the olfactory cortex. 
 The OSN receives sensory input from odorants via the olfactory receptors, which 




then travel through foramen in the cribiform plate and carry the signal to the CNS (Figure 
1A).  One unique property of OSNs is that they are regenerated throughout the adult life 
of all studied organisms.  Therefore, even beyond the developmental stage, new OSN 
axons are constantly targeting and integrating into existing central synaptic networks.  
The rodent olfactory bulb (OB) is the highly organized laminar structure that receives 
these OSN axonal inputs, making it the first step of odor processing in the central nervous 
system.  The organization of the OB is important to understanding how this level of 
processing works.  Interestingly, the cellular histology has been described long before the 
understanding of principles of odor coding, starting with the work of Ramon y Cajal in 
1911 (39).  Both the cellular and synaptic structures in rodent OBs are now well 
elucidated, and are reviewed in detail by Shepherd and Greer (40).   
There are several categories of neurons that play a role in odor processing at the 
level of the OB.  These include input neurons that carry information to the OB, output 
neurons that carry information out of the OB, and finally short axon intrinsic neurons that 
participate in the coordination of signals within the OB.  Input is received both from 
OSNs that carry the actual sensory information into the OB from the nose, as well as 
from regulatory centrifugal fibers consisting of axons from higher centers such as the 
olfactory cortex, the anterior olfactory nucleus, the basal forebrain, and several parts of 
the brainstem.  Output from the OB is sent through mitral cells and tufted cells, also 
known as the projection neurons.  Axons from these cells leave the OB at the 
posterolateral surface to form the lateral olfactory tract (LOT), which carries encoded 
olfactory information to the olfactory cortex.  Finally, additional regulation and 




Figure 1: Overview the Olfactory System and Olfactory Bulb 
The OSNs are schematically shown in A.  Their cell bodies are located in the olfactory 
epithelium, where they extend dendrites covered with the OR-expressing cilia into the 
mucus layer.  The OSN axons then travel through foramen in the cribiform plate into the 
OB, where they reorganize and regroup before finding their specific synaptic targets.  
The organization within the OB is based on clear laminar layers as shown through DAPI 
nuclear staining in a coronal section of an adult mouse OB (B).  The ONL contains the 
OSN axons surrounding the OB before entering the GL to find their synaptic targets.  
Next is the EPL, a cell-sparse area of dendrodendritic synapses, followed by the thin, 
cell-dense MCL, which contains the cell bodies of the projection neurons, the mitral cells.  
Deep to this is the IPL, and finally the GCL in the center, which contains the cell bodies 
of the granule cells, a type of interneuron in the OB.  Within the GCL newly generated 
neurons travel through the RMS to add to and replace existing interneurons in both the 
GCL and the GL.  Image in A adapted from http://www.colorado.edu/epob/ 
epob3730rlynch/image/figure8-18.jpg.  OB, olfactory bulb; OSN, olfactory sensory 
neuron; OE, olfactory epithelium; RMS, rostral migratory stream; GCL, granule cell 
layer; IPL, internal plexiform layer; MCL, mitral cell layer; EPL, external plexiform 








 intrinsic neurons, made up of periglomerular (PG) cells and granule cells. 
The layers of the OB are shown in an adult mouse OB in Figure 1B.  The most 
superficial layer is called the outer nerve layer (ONL), and consists of axons reorganizing 
into functionally related subsets before penetrating into the OB (34, 41).  Beneath the 
ONL lies the glomerular layer (GL).  This layer contains glomeruli, described in further 
detail below, which include the distinct synaptic units between the OSNs and the 
projection neurons.  Below the glomerular layer is the external plexiform layer (EPL) 
which contains the cell bodies of the tufted cells, as well as the dendrodendritic synapses 
between projection neurons and granule cells.  Next is the mitral cell layer (MCL), 
containing the cell bodies of mitral cells.  The internal plexiform layer (IPL) is a thin 
layer between the innermost granule cell layer (GCL) and the MCL, containing output 
axons from the projection neurons on their way to forming the LOT.  In the middle of the 
GCL, which contains the cell bodies of granule cells, is the rostral migratory stream 
(RMS), through which newly generated neurons travel from the subventricular zone 
(SVZ) where they are born, to their target destinations in the OB where they differentiate 
into new PG cells and granule cells.  
The complex synaptic circuits formed by these cells hold the key to understanding 
how odor signals are processed at this level within the OB.  A basic scheme of the main 
synapses is depicted in Figure 2, adapted from Mori et al. (42).  Within each glomerulus, 
the OSN axons synapse with the primary dendrites of mitral and tufted cells.  Any given 
projection neuron only innervates a single glomerulus.  However, these projection 




reciprocal dendrodendritic synapses with granule cells; the granule-to-mitral/tufted 
synapse is inhibitory while the mitral/tufted-to-granule is excitatory.   
In addition to the main axodendritic synapses between OSNs and projection 
neurons within the glomeruli, OSNs also form excitatory axodendritic synapses with PG 
cells.  Also within the glomeruli are reciprocal dendrodendritic synapses between PG 
cells and the mitral and tufted cells; the mitral/tufted-to-PG synapse is excitatory and the 
reciprocal is inhibitory. 
Within the GL but outside of the glomeruli, PG cell axons form inhibitory 
synapses both with other PG cell bodies and dendrites, as well as on the primary 
dendrites of projection neurons as they exit the glomeruli.  It can therefore be seen that 
PG cells are largely inhibitory in nature and are likely involved in negative feedback 
circuits. 
Collaterals from outgoing projection neuron axons on their way to the olfactory 
cortex form excitatory synapses with the cell bodies of granule cells within the GCL.  
The axon terminals from incoming centrifugal fibers are found in the GCL, the EPL, and 
in the extra-glomerular space of the GL, therefore providing regulation of olfactory 
signals from higher centers at multiple levels within the OB.  
 
Glomeruli are anatomical structures in the olfactory bulb with topographic 
specificity that play a functional role in odor processing.  
Glomeruli are the spherical regions within the OB neuropil that represent the 
primary synapse between OSN axons and projection neuron dendrites.  In mammals, 




Figure 2: Synaptic Organization of the Olfactory Bulb 
After OSNs enter the OB, they synapse with projection neurons, the mitral cells and 
tufted cells, within discrete synaptic units called glomeruli.  Also participating in the 
regulation of sensory input at this level are the PG cells, which form feedback circuits 
within the gomeruli with both the OSNs axons and the projection neuron dendrites.  The 
mitral/tufted cells send only a single primary dendrite into a glomerulus, however they 
send multiple secondary processes laterally that form synapses with granule cell 
dendrites.  The axons from the mitral and tufted cells then travel to the olfactory cortex 
where the final level of odor processing takes place.  White arrows represent excitatory 
synapses, black arrows represent inhibitory synapses. OSN, olfactory sensory neuron; 
GL, glomerular layer; PG, periglomerular cell; M, mitral cell; T, tufted cell; Gr, granule 









OSN projects to only a single glomerulus (45).  When examining the subset of OSNs 
expressing the same OR in rodents, it can be seen that their axons all project to one, two, 
or several distinct glomeruli (34, 46-48).  The most commonly seen scenario is axons 
projecting to exactly two glomeruli, one in the medial half of the OB and the other in the 
lateral half of the OB.  This specific targeting of glomeruli by OSN axons is made even 
more complicated by the fact that the three-dimensional positions of glomeruli are 
stereotyped from animal to animal within a species.  Spatial mapping has been 
undertaken through a variety of techniques, including 2-deoxyglucose uptake (49-51), 
optical imaging with voltage sensitive dyes (52, 53), and electrophysiological recordings 
from projection neurons (54).  All studies in all animals have shown that identical odors 
elicit characteristic spatial patterns of glomerular activity within the OB. 
Very little is known about the mechanism of specific glomerular targeting by 
OSN axons. In situ hybridization in rodents has demonstrated that OR proteins are 
present within the OSN axons and axon terminals (46, 47).  Later genetic studies were 
done in mice in which deleted OR coding sequences were substituted with different 
receptor sequences resulting in axon convergence to new glomerular targets (55, 56), 
showing that the OR itself plays a necessary role during axonal targeting.  OR guided 
targeting is presently believed to occur through G protein-coupled signaling via cAMP 
rather than by the direct action of OR molecules (10).  However, the new glomerular 
targets of these OSN axons were not exactly at the location of the substituted OR 




sufficient for exact targeting, and that the process is therefore more complex and likely 
involves multiple other determinants.    
 In addition to the targeting specificity of OSNs to glomeruli, there is also 
evidence of reciprocal specificity, in that all of the axonal inputs to a single glomerulus 
are specific to OSNs expressing a single OR.  Treloar et al. (57) demonstrated this in the 
mouse by using electron microscopy to show that all axons synapsing within a M72 
glomeruli express the M72 OR.   
These results further characterize the degree of molecular specificity encoded by 
the glomeruli, and additionally set up a numerical relationship between ORs and 
glomeruli.  If all OSNs expressing a given OR target a specific number of glomeruli in 
stereotypical positions in the OB, and all glomeruli are only receiving axonal input from 
one type of OR, the number of glomeruli should be directly related to the number of 
expressed ORs in any given species.  In mice, there are ~1000 expressed ORs, and the 
number of glomeruli has been estimated at ~1800 (58).  In rats, there are ~1200 expressed 
ORs (23) and the number of glomeruli in the rat OB has been estimated at ~2400 (59).  
There is therefore an approximate 2:1 relationship between the number of ORs and the 
number of glomeruli.  This confirms the previously noted observations that OSN axons 
for any given OR usually project to two glomeruli - one glomerulus medially placed in 
the OB and one that is laterally placed in the OB (34, 46-48); only rarely do they project 
to only one or more than two (35). 
      This specific organization of glomeruli in the rodent OB therefore creates a 
stereotyped map of ORs at this first level of central processing.  It is unclear what role the 




the ability of PG cells to regulate multiple proximally located glomeruli, as well as the 
ability of mitral and tufted cells that innervate separate yet adjacent glomeruli to form 
dendrodentritic synapses with each other via their secondary dendrites, it is indeed likely 
that the location and organization of the glomerular map has a functional role in 
regulating and integrating sensory information on its way to the olfactory cortex.  
Structurally similar odorants have been demonstrated to activate glomeruli in similar OB 
regions, creating chemotopic maps around the surface of the OB (60-63).  This, along 
with the growing understanding of the synaptic circuits involving closely proximated 
glomeruli, has popularized the idea that a key function of the glomerulus is to act as a 
signal-to-noise enhancing device (64).  Whatever the function(s) of glomeruli may be, the 
preservation of their anatomic localization and molecular specificity across all studied 




STATEMENT OF PURPOSE AND HYPOTHESIS 
 
Qualitative evaluation of the primary organization of the human olfactory bulb. 
Much work has been done to characterize the synaptic and molecular specificity 
of the OB glomeruli and their development.  Missing from these studies, however, is an 
analysis of the human olfactory system; a determination of whether the principles of axon 
convergence and molecular specificity that have been developed in rodent models extend 
to the human olfactory system.  Only a limited number of studies have been reported on 
the organization of the human OB and these were largely carried out prior to the 
development of our current molecular reagents or insights into the molecular organization 
of the OB.  Anecdotally, one can argue that the sense of smell in humans has degraded 
over evolution, but that hypothesis has not been pursued at the level of synapse formation 
or molecular specificity.  Consequently, we are interested in characterizing the primary 
organization of the human OB to begin to probe the widely held but untested hypothesis 
that the cellular, synaptic, and molecular organization in the human OB is less precise 
than that seen in other species. 
 
Assessing the rodent-based principles of molecular specificity in glomerular maps in 
the human olfactory bulb. 
Rodent studies have shown that the total number of glomeruli in the OB is a direct 
reflection of the number of intact ORs expressed in the olfactory epithelium; in rodents, 
there are twice the number of glomeruli as there are OR genes.  This leads us to the 




how similar odor processing is in these two species by counting the number of glomeruli 
present in human OBs.   Genomic mining in the human suggests a total of approximately 
350 OR genes with intact reading frames.  If the principles of axon convergence occur in 







Tissue Procurement and Fixation 
 Human OBs were obtained through several sources including both during autopsy 
from post-mortem donors as well as during neurosurgical procedures from live donors.  
OBs from autopsy were kindly made available by Dr. Jung Kim from the Department of 
Pathology, Yale University School of Medicine, New Haven, CT, as well as through the 
National Disease Research Institute, Philadelphia, Pennsylvania.  Information regarding 
age, gender, and relevant medical history was obtained for all donors (Table 1).  
Exclusions for this part of the study were the presence of symptomatic olfactory 
dysfunction, neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s 
Disease, and intranasal drug use.  Procurement of this tissue and relevant donor 
information passed HIC approval (#12081), and is exempt from IRB review under federal 
regulation 45 CFR 46.101(b)(4).  The post-mortem interval in these cases was less than 
16 hours, and after procurement the OBs were fixed in 10% formalin for 7 to 28 days.  
After fixation, these tissues were stripped of their meninges and washed two to three 
times overnight in fresh phosphate buffered saline (PBS).   
The live donor OBs were kindly obtained by Dr. Dennis Spencer of the 
Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, 
during frontal lobe neurosurgical cases requiring disruption of the lateral olfactory tract 
(HIC# 12081).  OBs were obtained only in those cases in which they would otherwise be 




paraformaldehyde for 24 to 48 hours.  After fixation, these OBs were stripped of their 
meninges and washed in PBS overnight. 
For qualitative comparisons, mouse OB tissue was also obtained.  Adult CD1 
mice (Charles River Laboratories) were anesthetized with sodium pentobarbital (80 
mg/kg i.p.; Nembutal; Abbott Laboratories, North Chicago, IL), then decapitated.  
Perfusions were avoided in order to more closely replicate the conditions under which the 
human OBs were obtained.  The mouse brains were removed from their skulls, and their 
OBs were removed and placed in 4% paraformaldehyde overnight, followed by PBS 
overnight.  All procedures undertaken in this study were approved by Yale University’s 
Animal Use and Care Committee and follow NIH guidelines. 
 After fixation, all human and mouse OBs were then cryo-preserved in 30% 
sucrose in PBS for 12 to 24 hours, then sectioned coronally throughout the length of the 
entire OB on a sliding-freezing microtome (50µm), and stored at -20°C until use.  To 
maintain rostral-caudal order in the human OBs, slices were maintained individually in 
48-well plates. 
   
Immunohistochemistry 
 Tissue was removed from -20°C storage and washed in PBS with 0.03% Triton 
100-X (PBS-T).  For antigen retrieval, OB slices were steamed for 10 minutes in a 
solution of 0.01M Sodium Citrate, then immediately washed with room-temperature 
PBS-T.  Tissue was blocked with 2% BSA in PBS-T for 45 minutes, then incubated for 
48 to 72 hours in primary antibody (see Table 2 for antibodies, concentrations, and 




in secondary antibody (Table 2) diluted in BSA-PBS-T for 2 hours along with a nuclear 
marker, DAPI (Sigma) and/or DRAQ5 (Alexis Biochemicals).  The sections were then 
washed in PBS-T, then PBS.  In order to eliminate autofluorescence from lipofuscin 
granules, sections were stained with 1% Sudan Black in 70% Methanol for 5 minutes, 
then cleared in 70% Ethanol and rinsed in PBS (65).  Sections were mounted with 
GelMount (Bioveda). 
 
Qualitative Characterization of the Olfactory Bulb 
 Antibodies as listed in Table 2 were used to characterize the organization of the 
OB.  MAP2 stains for dendrites, while GAP43 and NCAM are axonal markers.  VGlut2 
is a synaptic marker specific to OB glomeruli.  To look at different classes of neurons, an 
antibody against calretinin was used to identify neurons with this calcium binding 
protein, GAD65/67 to identify GABAergic neurons, and TH to identify dopaminergic 
neurons.  Antibodies against specific mouse odorant receptors, mOR50, mOR28, 
mOR256-17, and mOR267 were used to attempt to look at how axons expressing these 
individual odorant receptors were organized in the human OB.  All staining was done in 
at least four different human OBs, and presented images are typical unless stated 
otherwise.   
 Images were taken with the Leica confocal microscope at different magnifications 
to assess the immunofluorescent results at different levels of detail.  Images were also 
taken of mouse OB sections stained with the same antibodies for comparison of the 






 Every sixth section throughout the length of the human OBs was stained with 
anti-NCAM and anti-VGlut2 primary antibodies.  NCAM identifies the OSN axons, 
while VGlut2 is a synaptic-associated protein that in the OB is only found at the primary 
synapse between the OSN and the projection neurons, therefore defining the glomerular 
unit.  Glomeruli were identified by co-localization of VGlut2 and NCAM staining. 
Overlapping images were taken circumferentially around each section with an 
Olympus BX51 epifluorescent microscope using the 20X objective.  These digitized 
images were then analyzed using Metamorph software (Molecular Devices, Sunnyvale, 
CA).  Glomeruli were manually circled, while the software calculated total numbers of 
glomeruli as well as area and length/width diameters of each glomerulus.   
In this study, the length of the OB was defined by the distance encompassed by 
the most rostral and most caudal OB sections that exhibited glomerular staining.  The 
volume was calculated by estimating the shape of the OB to be a cylinder, and the cross 
sectional area was estimated by averaging the area of 4 slices distributed through the 
length of the OB.  The total counted glomeruli per OB was calculated by first multiplying 
the total number of counted glomeruli from the sections looked at by the inverse of the 
fraction of slices counted, usually around 6 as about every 6th slice was selected for 
counting.  Finally, to correct for the glomerular overlap between sections, the 
Abercrombie extrapolation was used: N = n * (t / ( t + H )), where in this case N is the 
number of glomeruli in the OB, n is the total number of counted glomeruli, t is the width 




Statistical analysis was performed using the Prism package (GraphPad Software 
Inc., San Diego, CA).  To look for relationships between the number of glomeruli and the 
age of the donors, the size of their glomeruli, or the volume of their OB, a linear 
regression test was performed.  To look for significance between the mean number of 
glomeruli in male donors versus female donors, as well as between “young” donors (<50 
years old) and “elderly” donors (>50 years old), an unpaired t-test was performed.  There 
were no significant differences in the viariances in either of these comparisons. 
 All of the above mentioned procedures, calculations, and analyses were 
performed by myself.  Dr. Diego Rodriguez Gil, a post-doctoral associate in the Greer 
lab, assisted with the statistical analyses.  Instruction and guidance was provided by all 







Table 1: Olfactory Bulb Donor Information  
     
OB 
Identification Source Type 
Age of 
Donor Gender Relevant Clinical Information 
HOB 1 Surgery 39 F frontal lobe epilepsy 
HOB 2 Post Mortem 89 M lung adenocardinoma 
HOB 6 Post Mortem 67 M leukemia treated with chemotherapy 
HOB 7 Surgery 66 M pituitary tumor 
HOB 15 Post Mortem 70 M emphysema  
HOB 16 Post Mortem 85 F microscopic polyangiitis  








Table 2: Antibodies Used for Immunohistochemistry 
    
Antibody Animal Dilution Source  
MAP2 chicken 1:1000 Sigma 
GAP43 rabbit 1:1000 Sigma 
NCAM mouse 1:500 Sigma 
VGlut2 rabbit 1:4000 Synaptic Systems 
calretinin mouse 1:400 Chemicon 
GAD65/67 mouse 1:1000 Stressgen 
TH rabbit 1:1000 Chemicon 
mOR50 guinea pig 1:3000 Dr. Richard Axel, Columbia University, New York, NY 
mOR28 rabbit 1:5000 Dr. Hitoshi Sakano, University of Tokyo, Japan 
mOR28 rabbit 1:5000 Dr. Richard Axel, Columbia University, New York, NY 
mOR256-17 rabbit 1:800 Dr. Heinz Breer, University of Hohenheim, Germany 
mOR262 rabbit 1:1500 Dr. Heinz Breer, University of Hohenheim, Germany 
    
chicken-Alexa 555 goat 1:1000 Molecular Probes 
rabbit-Alexa 555 donkey 1:1000 Molecular Probes 
mouse-Alexa 488 donkey 1:1000 Molecular Probes 








The laminar organization of the OB is broadly preserved in humans. 
The rodent OB is characterized by distinct laminar structures that can be 
identified using nuclear staining to evaluate the cellular distribution.  As can be seen in 
Figure 3A which depicts the layers of a mouse OB, the glomerular layer is clearly 
recognizable by the unique distribution of PG cells outlining individual glomeruli.  The 
EPL is an area of sparse nuclear staining as it is the area of dendrodendritic synapses 
between granule cells and projection neurons.  The thin band of dense nuclei represents 
the concentrated layer of mitral cell nuclei in the MCL.  Finally there is another cell-
sparse region, the IPL, followed by the cell rich GCL.  This is an extremely organized 
and distinctive pattern, seen consistently in all rodents throughout the rostral-caudal 
length of the OB. 
Figure 3A’ demonstrates the same DRAQ5 nuclear staining of a human OB.  
Clearly the layers are still present, though not as sharply demarcated as in the mouse OB.  
The GL is separated by the more superficial ONL by the presence of cell-absent spots, 
the glomeruli.  However, unlike in the mouse OB, the PG cells do not form clearly 
identifiable densities around the glomeruli, making individual glomeruli difficult to 
visualize in the human GL using nuclear staining alone.  Deep to the GL is the EPL, 
which is seen in this image to be relatively thin compared to the mouse, while the IPL is 
relatively thick compared to the mouse.  However, even within human OBs, there is 





Figure 3: Laminar Organization of the Human Olfactory Bulb 
Nuclear staining with DRAQ5 demonstrates the laminar layers of the mouse olfactory 
bulb (A) and the human olfactory bulb (A’).  While there is preservation of the laminar 
structure between the two species, the layers are more clearly demarcated in the mouse.  
In addition, the human OB demonstrates more variability in the width and organization of 
these layers, which are even sometimes completely absent.  Representative coronal OB 
slices show the structural variations both within single slices as well as between different 
OBs from different human donors (B-D).  In B, there are areas of very clear laminations 
(red arrow), as well as areas where the layers cannot be distinguished from each other 
(green arrow).  In C, the GL is completely absent around the left side, but in other areas 
the laminations are very clear (red arrows).  D also shows a partially circumferential GL, 
and in this OB the rest of the layers seem to be completely absent as the GL ends (yellow 
arrow).  GCL, granule cell layer; IPL, internal plexiform layer; MCL, mitral cell layer; 
EPL, external plexiform layer; GL, glomerular layer; ONL, olfactory nerve layer.  Scale 









This variability can be seen circumferentially within one OB slice, as well as 
between slices from OBs from different donors.  Figure 3B-D shows examples of slices 
stained with DRAQ5 from three different donors.  In Figure 3B, the GL can be seen 
around the entire circumference of the OB.  The different layers, including the frequently 
elusive MCL, are clearly demarcated through the entire depth in some areas (red arrow), 
however seem to blend together deep to the GL in others (green arrow).  In Figure 3C, 
the GL is absent around the left side of the bulb.  Despite the absence of glomeruli, there 
is evidence of lamination suggesting that some level of organization persists.  Again, as 
in the previous image, there are points throughout the rest of the OB’s circumference 
with very clear laminations (red arrow) while in other areas the laminations are less clear.   
The final image (Figure 3D) shows another example of an OB with a glomerular 
layer that is only partly circumferential.  However, as opposed to in the previous image, 
the laminations are completely absent along the top of the slice where there are no 
glomeruli, and even the density usually seen around the periphery of the central GCL 
disappears when the glomerular layer ends (yellow arrow).  In this OB, the ONL and GL 
are extremely thick compared to the other OBs pictured.  
 
Distribution of OSN axons in glomeruli depends on axonal maturity. 
 The OB is a dynamic region of the central nervous system; as seen in other 
species, OSNs are constantly regenerated/replaced and send their newly forming axons 
through the cribiform plate into the OB, where they seek out their target glomeruli and 




OSN axons in the human OB, sections were co-stained with GAP43, which recognizes 
immature axons in the process of finding and integrating into their target synaptic 
networks, as well as NCAM, which stains all axons.   
The GAP43 pattern of staining in a mouse OB demonstrates GAP43+ axons 
clearly co-localizing with the NCAM+ axons in the ONL as well as glomeruli (Figure 
4A).  This staining pattern is also represented in the human (Figure 4B).  While the 
overall architecture of the OB laminations are not as precise, the distribution of GAP43+ 
stained axons is similar, with co-localizations seen in the ONL and glomeruli.  This 
image is from HOB 1, taken from a 39 year-old donor, demonstrating clearly that OSNs 
are generated and replaced in adult humans.  The oldest OB examined was HOB 2, taken 
from an 89 year old donor (Figure 4C).  In this OB as well, which qualitatively has even 
poorer laminations than in the previous OB from a younger donor, GAP43+ axons are 
still visualized in glomeruli, demonstrating the persistence of OSN proliferation in 
humans through the entire adult life into old age.   
A closer look at a glomerulus as defined by the NCAM stained OSN axons, 
demonstrates the GAP43 staining around the periphery (Figure 4D).  This is consistent 
with observations in rodents, in which new OSN axons are integrated on the outside of an 
existing glomerulus, while the more mature axons are more centrally located (66).  As 
additional new axons expressing the same OR arrive at their target, they in turn surround 
the outside of the glomerulus, and the previous axons that are now maturing and 






Figure 4: Presence and Distribution of Newly Generated Olfactory Sensory Neurons 
Axons from newly generated OSNs are identified by co-localization between GAP43 
(red) and NCAM (green).  These axons can be seen in abundance in the ONL and 
glomeruli of the mouse OB (A), showing that newly generated axons are able to integrate 
into the OB synaptic network.  Evidence of OSN regeneration in humans is presented in 
B-D, where these axons are seen in the ONL and glomeruli similarly as in mice.  The OB 
slice stained in image B is from a 39 year old donor, while the OB in C is from an 89 year 
old donor, indicating that OSN regeneration continues well into old-age.  D is a higher 
magnification showing that new OSN axons first integrate into the periphery of existing 
glomeruli, a process that has been previously described in rodents.  EPL, external 








Glomeruli in the human OB show evidence of compartmentalization. 
Previous work in rodents has demonstrated compartmentalization of glomeruli 
into axonal and dendritic compartments (67-69); the axonal compartments are where the 
axodendritic synapses between OSNs and projection neurons take place, while the 
dendritic compartments are where the dendrodendritic synapses between the PG cells and 
the mitral and tufted cells take place.   
To examine whether there was evidence of compartmentalization in human 
glomeruli, OB slices were co-stained with NCAM, an axonal marker, and MAP2, a 
dendritic marker.  Figure 5A and B show the distribution of these two markers in the 
mouse and human OBs respectively.  In both species, the MAP2+ dendrites are especially 
prominent in the EPL, the area of dendrodendritic synapses.  Dendrites are also 
demonstrated extending into glomeruli in the GL, with some degree of co-localization 
visible even at this low magnification between these MAP2+ dendrites and NCAM+ 
axons.  
By examining higher magnifications of glomeruli (Figure 5C, D), the axonal and 
dendritic compartmentalizations previously described only in the rodent are demonstrated 
here in the human OB.  The axonal areas are demarcated by the green NCAM+ staining 
with some evidence of co-localization with the red MAP2+ staining, representing the 
OSN-projection neuron axodendritic synapses.  The dendritic areas are NCAM-, but 
MAP2+, representing areas of dendrodendritic synapses as previously described.  This 
suggests that at the intraglomerular level, axodendritic primary afferent synapses and 
local circuit dendrodendritic synapses remain segregated in the human OB and therefore 




Figure 5: Evidence of Glomerular Compartmentalization  
In rodents, separate axonal and dendritic compartments have been defined in glomeruli, 
segregating the axodendritic synapses from the local circuit dendrodendritic synapses.  
The broad distribution of dendrites and OSN axons is demonstrated in a mouse OB (A) 
using MAP2 (red) and NCAM (green).  Nuclear staining with DRAQ5 (blue) is also seen 
in A, B.  As expected, the EPL is rich in MAP2+ dendritic staining, with both MAP2 and 
NCAM staining seen in the glomeruli.  A similar organization is seen the human OB (B) 
as in the mouse.  Higher magnification of glomeruli from the human OB (C,D) shows 
areas specific to NCAM staining and areas specific to MAP2 staining.  These represent 
axonal and dendritic compartments respectively, suggesting that there is preservation of 
the synaptic organization within glomeruli between rodents and humans.  EPL, external 











Periglomerular cells in the human OB do not form uniform densities around 
glomeruli, however they represent a similar heterogeneous population of cells as in 
rodents. 
 As described earlier, glomeruli in the mouse OB can be identified with nuclear 
stains by their surrounding PG cells, while in the human OB, this method of identifying 
glomeruli is not as clear.  To further evaluate the distribution of PG cells in the human 
OB, nuclear staining was combined with staining for NCAM, an axonal marker, and 
VGlut2, a synaptic marker specific to glomeruli; co-localization of these two probes is a 
more rigorous way of defining glomeruli, and therefore provides a way of visualizing the 
relationship between PG cells and glomeruli.   
The DRAQ5 staining of a mouse OB shows PG cell densities clearly demarcating 
the borders of glomeruli (Figure 6A).  Confirmation of these glomeruli is demonstrated 
with the added NCAM and VGlut2 staining to this image, clearly showing glomeruli 
within the PG cell circumferential densities (Figure 6B).  However, DRAQ5 nuclear 
staining from sections of a human OB are far less convincing in their ability to delineate 
glomeruli through examination of PG cells (Figure 6C,E). There are areas of more 
sparsely distributed cells, some of which hint at the potential locations of glomeruli, 
however only rarely do the PG cells identify clear glomerular borders.  When NCAM and 
VGlut2 staining is added to the images (Figure 6D,F), easily identifiable glomeruli are 
now able to be seen within the PG cells.  This PG cell organization appears to be unique 




closely approximated glomeruli with evenly distributed PG cells consistently surrounding 
every individual glomeruli, the human OB GL appears more chaotic in nature.  As 
described in more detail below, glomeruli in the human GL appear to be distributed 
randomly, often appearing in clusters or as a lone individuals.  When in a cluster, there is 
a relative paucity of directly approximated PG cells relative to the central glomerular 
bodies.  When spaced farther apart, there are large areas of intervening PG cells that have 
no physical approximation to any glomerulus; it is rare due to the compact nature of the 
rodent GL to see PG cells that are not directly abutting or within close approximation to a 
glomerulus.  Therefore, while the GL does qualitatively appear to be rich in PG cells in 
humans, there does not appear to be homogeneity in the distribution of PG cells relative 
to glomeruli as there does in rodents. 
 PG cell populations and their chemical heterogeneity have been well described in 
rodents (70).  Their heterogeneity is usually defined by several substances; glutamic acid 
decarboxylase (GAD), a key enzyme in the synthesis of GABA (71-74), tyrosine 
hydroxylase (TH), a key enzyme in synthesizing dopamine (75, 76), and several calcium 
binding proteins, including calretinin (77, 78).  As PG cells are primarily inhibitory, it is 
no surprise that many if not all of them contain GABA and/or dopamine, two of the 
primary inhibitory neurotransmitters.   
By immunohistochemical staining with antibodies for each of these distinct PG 
cell markers, the relative qualitative distributions of PG cell types can be compared 
between humans and mice.  Figure 7A demonstrates the population of dopaminergic cells 
in a mouse OB using antibodies for TH, along with NCAM to define the glomeruli.  TH+ 




Figure 6: Defining Glomeruli With NCAM and VGlut2 Co-Localization 
Due to the well organized compact nature of glomeruli within the GL in the mouse OB, it 
is easy to define glomerular borders based on the presence of surrounding PG cell 
densities using DRAQ5 nuclear staining (A).  The locations of these glomeruli are 
confirmed by the addition of NCAM (green) and VGlut 2 (red) to the DRAQ5 staining 
(blue) (B) of the same image.   However, in the human OB, the glomeruli are not 
regularly and compactly organized, and the PG cells do not form clear circumferential 
densities around their borders, making identification with DRAQ5 staining alone difficult 
(C,E).  However, the addition of NCAM and VGlut2 in these same images is able to 
define the locations of these glomeruli clearly (D,F).  In addition to highlighting the 
degree of variability in the size, shape, and distribution of the glomeruli, this also allows 
for the better characterization of the relationship between glomeruli and surrounding PG 
cells, which is also demonstrated to be more variable than compared to mice.  EPL, 









staining processes can be visualized extending into the glomeruli, representing the PG 
cell axons that synapse with the dendrites of projection neurons as well as occasionally 
with the axons of the OSNs.  Though not pictured, rare TH+ cells can also be seen in the 
deeper layers in the mouse OB.   
Figure 7B shows TH staining in the human at low magnification.  Again, cell 
bodies are seen in the GL.  While many are closely approximating glomeruli, some are 
more isolated within the GL.  This image also depicts several TH+ cell bodies within the 
GCL.   By observation, the percentage of cells in the GL that are TH+ appears to be 
lower than in the mouse.  At higher magnification (Figure 7C) the large-bodied TH+ cells 
are seen surrounding the glomerulus, with processes extending into the glomerulus; areas 
of co-localization are present between these TH+ processes and NCAM+ OSN axons.  
Calretinin+ PG cells can be seen in the mouse OB surrounding glomeruli defined 
by VGlut2 staining (Figure 7D).  These cells are more abundant than the dopaminergic 
cells, and have smaller cell bodies.  Calretinin+ cells are also found with relatively high 
frequency in the deeper layers of the OB.  Calretinin stains processes very strongly, and 
even at this low magnification, calretinin+ staining can be seen within the glomeruli.   
In the human, the calretinin+ PG cells are also more frequent than dopaminergic 
PG cells (Figure 7E).  These cells seem to be more closely approximated with glomeruli 
than TH+ cells, only rare calretinin+ cells are seen in the GL that are not directly 
approximated with a glomerulus.  Again, the strongly staining processes are seen in the 
glomeruli, even at the low magnification the co-localization between VGlut2 and 
calretinin can be seen.  This is better pictured in the higher magnification image (Figure 




Figure 7: Molecular Phenotypes and Distributions of Periglomerular Cells 
Large-bodied TH+ (red) cells are seen surrounding glomeruli, as defined by NCAM 
(green), in the mouse OB (A).  A similar distribution is seen in the human OB (B).  A 
closer look at a single glomerulus in the human OB (C) demonstrates the large-bodied 
TH+ cells surrounding and sending processes into the glomerulus.  Calretinin+ (green) 
cells have smaller cell bodies, and are seen in a mouse OB even more abundantly staining 
PG cells around glomeruli, in this case identified with VGlut2 (red) (D).  A similar 
distribution is seen in the human OB, with many calretinin+ PG cells surrounding the 
unevenly distributed glomeruli, into which they are extending many darkly stained 
processes.  This is seen in greater detail in F, which also demonstrates more clearly the 
smaller cell bodies of calretinin+ cells.  The GAD65/67 antibody stains processes very 
darkly, and the EPL is dense with these GAD65/67+ (green) processes in the mouse OB 
(G), however abundant GAD65/67 cell bodies can be seen surrounding the VGlut2+ (red) 
glomeruli.  The EPL is similarly dense with processes in the human OB (H), and 
processes can also be seen around the glomeruli in the GL.  At a higher magnification in 
the GL of a human OB (I), fewer cell bodies are obviously GAD65/67+ as compared to 
in the mouse, some of the more clearly stained cells are identified with arrows.  However, 
this is likely due to the poor staining quality of the antibody, in fact most PG cells have 
some degree of co-localization with GAD65/67.  The quantities and distributions of these 
classes of cells are therefore seen to be similar in mice and humans, suggesting 
similarities between local processing of olfactory signals at this level.  DRAQ5 staining 
of nuclei is blue in all images.  EPL, external plexiform layer; GL, glomerular layer.  








fairly high density. 
GABAergic cells are characterized by staining with an antibody against 
GAD65/GAD67.  Glomeruli were defined with VGlut2.  This antibody has relatively 
poor staining of cell bodies while staining of the processes is very strong.  A large 
amount of staining of these processes is seen in the EPL of the mouse OB, with cell 
bodies pictured very densely packed around glomeruli in the GL (Figure 7G).  These 
cells have medium-sized cell bodies, and are the most abundant of the PG cells, which is 
consistent with the finding is this image. 
In the human OB, GAD65/67+ staining is particularly prominent in the EPL as 
well (Figure 7H).  Less densely stained processes can be seen around the glomeruli, 
however no distinct cell bodies can be identified at this low magnification.  At higher 
magnification, several VGlut2+ glomeruli can be seen surrounded by GAD65/67+ cells 
(Figure 7I).  Due to the poor cell body staining, GABAergic cells are difficult to clearly 
identify; several of the more prominently stained cells are labeled with an arrow.  
However, upon close examination, many of the DRAQ5 stained nuclei surrounding these 
glomeruli demonstrate small but visible co-localization with GAD65/67.  This, combined 
with the clearly identified GAD65/67+ processes surrounding and innervating the 
glomeruli confirms the localization of GABAergic PG cells in the GL.  Unfortunately the 
staining quality prohibits further speculation about the relative quantities of these cells as 
compared to rodents. 
In summary, all three types of PG cells, including dopaminergic cells, 
GABAergic cells, and cells expressing calcium binding proteins, are present in the GL of 




the exception of the GABAergic cells in which no conclusions could be made due to 
limitations in the immunohistochemical staining in the human OB.  Finally, all three 
types of cells appear to be distributed in the OB similarly as in mice, and most notably in 
the GL they are all closely surrounding the glomeruli.  While not conclusive, these 
histological descriptions are consistent with the idea that the same types of synaptic 
circuits between OSNs, mitral/tufted cells, and PG cells are also present in the human and 
may play a role in the initial processing of sensory input into the OB.   One important 
observation, however, is that in the GL in the human OB there does not appear to be 
homogeneity in the distribution of PG cells relative to glomeruli as there does in rodents, 
and there are large areas within the GL without glomeruli that are still dense with PG 
cells.  Interestingly, while the PG cells directly surrounding glomeruli in the human were 
stained consistently with the TH, GAD65/67, and calretinin antibodies, only rare PG cells 
in these intervening areas were stained.  It is unclear what the nature of the cells in these 
areas are or how they may contribute to the synaptic organization in this layer.  
 
The distribution of glomeruli in the OB is not preserved between specimens. 
 Rodents have very specific odor maps, with stereotyped locations of glomeruli for 
each specific OR that are conserved from animal to animal.  For each OR, there are 
usually two, though sometimes one or a few, glomerular targets, one located on the 
medial wall of the OB and the second located on the lateral wall.   These precise odor 
maps in mice are composed of regularly-spaced glomeruli evenly distributed almost two-




 To broadly look at the general distribution of glomeruli in the human OB, slices 
were co-stained with NCAM and VGlut2.  By looking at representative low 
magnification slices arranged rostrally to caudally throughout the length of one of the 
OB’s, HOB1 (Figure 8), it can be seen that the distribution of glomeruli around the OB is 
very different in humans than in mice.  While in mice they are regularly spaced in a thin, 
circumferential layer, in the human OB glomeruli are often clustered in groups.  In the 
images presented, these clusters are represented by thick NCAM+ axon densities that 
branch out into large groups of VGlut2+ glomeruli that are often overlapping and that 
extend the width of the GL deeper into the OB.  There are several of these clusters that 
can be seen throughout the representative slices.  They are in different areas of the 
circumference, though the overall distribution of glomeruli in this OB is lateralized to 
about half of the overall circumference.  This localization remains consistent throughout 
the entire length of the OB until it tapers off at the most caudal end.  Outside of the 
clusters, the other areas along the circumference seem to have a more uniform thickness, 
however even here the distribution of glomeruli is not evenly spaced as they are often 
clumped together or completely absent.     
 This non-circumferential distribution was seen in all OBs examined, however the 
extent to which the glomeruli were limited to one area was variable from specimen to 
specimen, as was the particular area to which they were localized.  Representative low 
magnification slices from several different human OBs, taken from mid-OB except where 
noted, demonstrate the variety in the distribution around the OB (Figure 9).  HOB 20 
(Figure 9A) and HOB 6 (Figure 9B) have a similar type of lateralization as was seen in 




Figure 8: Limited Circumferential Localization of Glomeruli  
The localization of glomeruli around the circumference of a single OB, HOB 1, through 
its rostral-caudal length is shown starting rostrally in A and ending caudally in H.  
Glomeruli are identified by co-localization of NCAM (green) and VGlut2 (red).  Nuclear 
staining is with DAPI (blue).  Clusters of glomeruli can be seen in the GL with 
intervening areas that are more sparse in glomerular density, unlike the mouse OB in 
which the glomeruli are regularly spaced, and usually only 1-2 glomeruli thick.  The 
thickness of the GL shown here is variable amongst slices, but the non-circumferential 
lateralization of glomeruli remains consistent throughout the entire length.  Scale bar in H 









in HOB 1, while HOB 6 has a very thin ONL and sparse glomeruli.   In several of the 
OBs including HOB 20, the glomeruli could be seen completely circumferentially in the 
most rostral slices (Figure 9C) until becoming more localized in their distribution.  HOB 
15 had a particularly large distribution, almost completely circumferential (Figure 9D).  
HOB 7 and HOB 2 had distributions that each covered about half of the circumference, 
however, each was distinctive in their localization; in HOB 7 glomeruli were lateralized 
side-to-side, while in HOB 2 they were lateralized up-to-down (Figure 9E,F).  These 
images highlight the broad spectrum of variations in the glomerular pattern, both in the 
amount or the circumference surrounded by glomeruli as well as in the localization 
within the circumference.  This variability demonstrates that, as opposed to in rodents, it 
is unlikely that humans have a stereotypical spatial targeting within the OB for axons 
expressing specific ORs that is identical amongst all members of the species.  
To try to explore this further and examine the localization of specific OR 
glomeruli, slices throughout the OB were stained immunohistochemically with probes for 
several ORs (see Table 2).  These included antibodies targeting mOR50 (Mori), mOR28 
(Sakano), mOR28 (Axel), mOR256-17 (Breer), and mOR262 (Breer).  ORs are expressed 
in the axons of OSNs, so successful staining should demonstrate OR+ axons surrounding 
the OB in the ONL, as well as OR+ glomeruli representing the glomerular targets for the 
specific OR.  Although these antibodies were developed against mouse ORs, it was 
hoped that they might recognize human ORs as well, since as previously discussed, there 
is a high though variable degree of sequence homology between OR genes from the two 
species.  By seeing OR+ glomeruli, this study might be able to confirm molecular 




Figure 9: Variability in Glomerular Localizations  
The broad range in glomerular distributions is shown in OBs from several different 
donors.  Glomeruli are identified by co-localization between NCAM (green) and VGlut2 
(red), nuclear staining is with DAPI (blue).  The most rostral tip of several of the OBs, 
such as HOB 20, exhibited glomeruli around the entire circumference of the OB (C), after 
which they usually became far more localized.  Other than C, all images in this figure are 
taken from slices that are mid-OB.  The most common localization is shown in HOB 20 
and HOB 6 (A,B), however the laminar organization is very different between these two 
OBs, with HOB 20 having a very thick GL and dense glomeruli, and HOB 6 having a 
very thin GL and sparse glomeruli.  In HOB 15 (D), glomeruli are seen surrounding 
almost the entire OB, with some glomeruli extending out of the GL deeper into the bulb.  
In HOB 7 and HOB 2 (E,F) glomeruli are seen surrounding about half of the 
circumference, however in HOB 7 the lateralization is side-to side while in HOB 2 the 
lateralization is top-to-bottom.  While rodents have a very stereotypical odor map that is 
preserved from animal to animal, because of the broad ranges in the distributions of 
glomeruli around the OB, it is unlikely that this is the case in humans.  Scale bar in H is 









Figure 10: Single Odorant Receptor Expression in the Olfactory Nerve Layer  
In order to examine the distribution of single-OR axons and glomeruli, human OB slices 
were stained with a mix of antibodies developed against individual mouse ORs, which 
included mOR50 (Mori), mOR28 (Sakano), mOR28 (Axel), mOR257-17 (Breer), and 
mOR262 (Breer).  Due to the high degree of homology between human and mouse OR 
sequences, it was hoped that these antibodies would recognize human ORs as well. 
Evidence of positively stained axons with characteristic knobby densities are present in 
ONL (A,B), however no glomeruli were visualized.  ONL, olfactory nerve layer.  Scale 









distribution of specific OR glomeruli in the bulb, and might be able to provide further 
insight into the numbers of glomeruli targeted by OSN axons for each OR. 
 Unfortunately, while there was no conclusive evidence of OR+ glomerular 
staining, there was suggestive OR+ staining in the ONL (Figure 10A,B), which implies 
that the OR antibodies developed against mouse sequences are able to cross-react with 
humans.  However, due to the lack of identified glomerular staining, no further insight 
was provided regarding homotypic axon convergence or molecular specificity of the 
glomeruli. 
 
Humans have many more glomeruli than models of olfactory processing established 
in rodent models would predict. 
 In rodent models, the total number of glomeruli in the olfactory bulb is a direct 
reflection of the number of intact ORs expressed in the olfactory epithelium.  In both rats 
and mice, there are twice as many glomeruli as there are OR genes.  By evaluating the 
number of glomeruli in humans, it can be determined whether principles of axon 
convergence occur in the human as they do in the rodent.  We used co-localization of 
NCAM and VGlut2 to define glomeruli.  In addition to counting the glomeruli from 
representative slices throughout each OB, each glomerulus was circled to measure its 
two-way diameter and area.   
Table 3 shows the final results of this study for the seven OBs that were 
examined.  The average number of glomeruli was 5568 ± 830 (mean ± S.E.M.), many 
times more than the 700 predicted based on the estimated 350 intact OR genes in humans.  




smallest number counted was 2975 from HOB 6, and the highest 9325 from HOB 20.  
While based on a small n, these huge counts are many times higher that predicted, and 
seem to clearly disprove the hypothesis that there would be about 700 glomeruli.  This 
implies that through evolution, in the time since primate-rodent divergence, humans have 
developed different principles of axon convergence and glomerular targeting, which in 
turn may reflect a variation in the way odor is processed at this level. 
The glomerular diameters were calculated based on two-way measurements 
across the circled glomeruli, with an average diameter of 59.6 ± 1.4 µm.  However, this 
standard error represents the range of glomerular diameters averaged from each of the 
OBs.  In fact the actual range of diameters was much larger than this, with the smallest 
measured glomerulus having a diameter of 15.8 µm and the largest measured glomerulus 
having a diameter of 185 µm.  In addition to this huge variation in size, these human OB 
glomeruli exhibited extreme variations in shape, with often the two axis measurements 
being extremely disparate for a given glomerulus.  However, the two diameters defining 
the individual glomerular shapes averaged out to within only a few microns for each of 
the OBs.  This indicates that the average two-dimensional shape of glomeruli in the 
human is circular despite the huge variability between individual glomeruli, and therefore 
the average structural shape is spherical.   
The average length of the OBs, defined by the rostral-caudal distance between the 
first and last coronal slices that contained glomeruli, was 9.52 ± 0.49 mm.  The mean area 
of the coronal cross-section of the OBs was 5.52 ± 0.32 mm2, and was seen within an 
individual OB to remain fairly consistent throughout the length except at the most rostral 







      
Table 3: Olfactory Bulb Analysis Data    
      
ID OB Length (mm) 
Average Area 










HOB 1 7.05 4.30 30.32 65.13 4595 
HOB 2 9.60 5.99 57.50 55.15 4184 
HOB 6 9.50 5.73 54.44 56.17 2975 
HOB 7 11.35 4.39 49.83 59.29 6530 
HOB 15 9.40 6.28 59.03 57.44 7150 
HOB 16 9.35 5.64 52.73 62.68 4221 
HOB 20 10.40 6.28 65.31 61.37 9325 
Mean ± S.E.M. 9.52 ± 0.49 5.52 ± 0.32 52.74 ± 4.19 59.60 ± 1.41 5568 ± 830  





than like an elliptoid.  Using this assumption of a cylindrical shape, the mean volume of 
the OB was calculated to be 52.74 ± 4.19 mm3.  Previous MRI imaging has measured the 
volume of OBs from patients with normal olfaction to be from 59 mm3 to 119 mm3 (79).  
While this is a bit higher than the volumes seen in our study, this likely reflects the fact 
that we used a functional definition of volume based on the presence of glomeruli, which 
is a clear way of identifying the transition between OB and LOT, and which was seen to 
occur before the anatomic narrowing of OB to LOT was clearly visible.  
  
There is no relationship between number of glomeruli in human OBs and either age, 
gender, or OB size. 
There was a huge range in the number of glomeruli counted from these seven 
human OBs.  To look for possible associated factors, the relationship between the number 
of glomeruli and the age of the donor, the gender of the donor, the average diameter of 
the glomeruli, and the size of his/her OB was examined.  A previous study described an 
inverse relationship between age and number of glomeruli (80); however, we did not find 
a correlation between the two variables as measured with a linear regression test (p=0.39) 
(Figure 11A).  When placed in two age categories of “young” (age less than 50 years old) 
and “elderly” (age greater than 50 years old), the average number of glomeruli in OBs 
from the the “young” group was 6960 ± 2365 (n=2), while in the “elderly” group it was 
5012 ± 785 (n=5) (Figure 11B).  While there are fewer glomeruli in OBs from the 
“elderly” group, using an unpaired t-test this difference was not found to be significant 
(p=0.33).  These findings are different from those of Meisami’s group, and possible 




In addition, the data was grouped by gender, with the average number of 
glomeruli in OBs from female donors calculated as 6047 ± 1643 (n=3), and from male 
donors, 5210 ± 981 (n=4) (Figure 11C).  There is no statistical significance between these 
groups either (p=0.66).  Finally, there was no correlation between glomerular number and 
average glomerular size (p=0.71) (Figure 11D), or between glomerular number and OB 
volume (p=0.31) (Figure 11E).  
Based on the small n of 7, there is not a large amount of data to support the power 
of these comparisons.  Nevertheless, the only relationships that begin to even support a 
trend are between number of glomeruli and OB volume, as well as number of glomeruli 
and age.  Only by increasing the number of human OB samples can it be seen whether 
true relationships develop in these cases.   However, it is most likely that the main 
sources of variation in the number of glomeruli between different individuals lie outside 




Figure 11: Relationships Between Total Glomeruli and Age, Gender, Glomerular 
Diameter, and Olfactory Bulb Volume 
No significant relationship were found between total glomeruli and donor age (p=0.39) 
(A).  There was a trend towards decreasing numbers of glomeruli with increasing age, 
however even when split into two groups of “young” (age less than 50 years old) and 
“elderly” (age greater than 50 years old), the difference was not significant (p=0.33).  The 
average number of glomeruli in OBs from the “young” group was 6960 ± 2365 (n=2), 
while in the “elderly” group it was 5012 ± 785 (n=5) (B).  When grouped by gender, the 
mean number of glomeruli in OBs from female donors was 6047 ± 1643 (n=3), and from 
male donors, 5210 ± 981 (n=4), which was also not significant (p=0.66) (C).  Finally, 
there was no correlation between glomerular number and average glomerular size 
(p=0.71) (D), or between glomerular number and OB volume (p=0.31) (E).  Linear 
regression tests were performed to look for significance in A, D, E.  Unpaired t-tests were 
performed for the two-group comparisons in B, C.  There were no significant differences 











The organization of the human OB is preserved, but is less precise than in rodents. 
 Previous work to describe the human OB histologically was largely undertaken 
before the availability of our current molecular reagents or insights into the molecular 
organization of the olfactory bulb.  Early immunohistochemical analyses were able to 
define the presence of synapses and several classes of PG cells, such as those examined 
here, within the human OB (81-86), but at the time there was very little understanding of 
the intricate neuronal circuits involved in the OB.  In fact, most of these studies were 
performed before the odorant receptor had even been identified by Buck and Axel in 
1991 (8), the discovery that pioneered the understanding of molecular specificity and 
glomerular odor maps.   
Much of the recent work done with the human OB tissue is related to clinical 
interests in how different diseases, especially neurodegenerative diseases, manifest in the 
OB.  These studies, summarized below, provide little insight into the actual organization 
of the human OB that is relevant for understanding how it compares to that of the rodent 
models in which the principles of odor processing were first discovered.  Therefore, this 
current work, while by no means comprehensive, is novel in providing an initial look at 
the organization of the human OB with regard to these important principles. 
The qualitative evaluation of the human OB presented here evaluates several 
components of OB organization, including the preservation of laminar layers, the 
presence and distribution of new OSN axons, the compartmentalization of glomeruli, the 




glomeruli around the OB.  Because so much that is now understood about odor 
processing in rodents has a defined anatomical basis, such anatomical studies of the 
human OB can provide insight into similarities and differences between odor processing 
in these two species.  Based on these analyses, there are several lines of evidence that 
support the preservation of OB organization in humans, while several others highlight 
potential differences between the two. 
Definitive evidence is presented here that, as in rodents, OSNs are regenerated 
throughout the entire adult life of humans, and that these new axons integrate into 
established glomeruli in a manner typical to what is seen in rodents.  This dynamic nature 
of the sensory input requires the coordination of factors related to axon growth, guidance, 
and integration within synaptic networks in order to maintain the complex organization 
within the OB.  Any failures in these processes that detract from OB organization may 
have functional consequences in the efficiency and accuracy of odor processing.  While 
not evaluated here, there is preliminary evidence that in humans, as in rodents, new PG 
cells and granule cells are also regenerated (87).  If true, this would add additional 
complexity to the dynamic nature of the organization of the human OB. 
Olfactory function is known to decline steadily after the age of 40 (88), with a 
prevalence of olfactory dysfunction in elderly people as high as 70% (89).  This occurs 
despite the ability to regenerate OSNs.  Therefore, a potential explanation for this age 
related decline in olfactory function is in fact an accumulation of organizational errors 
due to inaccuracies in axon targeting and synaptic integration of these newly generated 
neurons over time.  Due to the complicated integration of sensory information between 




cells from the GCL, such errors might have organizational consequences throughout the 
entire OB.  In possible support of this hypothesis, there appeared to be qualitative 
differences between the OBs from younger donors compared to older donors, with older 
donors demonstrating strikingly less clear laminations in the OB structures.  Contributing 
to this apparent decline in the clear demarcations between cell types and synapses is the 
presence of glomerular structures that extend beyond the GL into the EPL, observations 
that were also noted indirectly by several groups of clinician investigators (90, 91).   
Therefore, while laminar organization is a concept that is preserved in the human OB, 
because it is such a dynamic structure, perhaps over the long duration of the lifetime of a 
human inaccuracies accumulate that have anatomic and functional consequences. 
At the level of the glomerulus, there were several observations in this study that 
suggest that the local synaptic regulation of incoming sensory signals is preserved in 
humans.  The PG cells have molecularly defined identities that are similar to that 
described in rodents with similar distributions surrounding the glomeruli.  Additionally, 
glomeruli have segregated axonal and dendritic compartments that represent, 
respectively, the axodendritic synapses between OSNs and mitral/tufted cells, and 
dendrodendritic synapses involved in local PG cell circuits.  Despite these important and 
revealing similarities, there are general organizational differences in the GL between the 
two species that bear discussion.  While the GL in mice is composed entirely of glomeruli 
with surrounding PG cell densities, as seen in this study, the GL in human OBs contains 
clusters of glomeruli without the surrounding PG cell densities that are seen in mice, as 




The clusters of glomeruli with a relative paucity of surrounding PG cells may be 
another example of changes in the structural organization of the human OB that may have 
functional consequences and contribute to the evidence that humans have a weaker sense 
of smell.  PG cells play an important role in local feedback circuits in the GL that may 
serve to increase the sensory signal as well as potentially inhibit signals from areas of 
input represent similar but different odors.  Therefore, efficiency at this level may be 
reflected in low odor detection thresholds as well as the ability to discriminate between 
different odors.  Accordingly, having low as well as variable ratios of PG cells to 
glomeruli, it can be seen that there may be functional consequences in these measures of 
olfaction. 
However, perhaps glomeruli do not necessarily need to be abutting the PG cells 
with which they form synapses.  There are many areas dense in PG cells without 
proximal glomeruli.  PG cells are able to extend long processes, as seen in the TH, 
calretinin, and GAD65/67 staining presented in this study.  Therefore, even without the 
physical proximity it is possible that these PG cells are involved in local circuits from a 
greater distance, and the density of PG cells seen surrounding glomeruli in mice is simply 
to maximize the efficiency of a limited GL space, rather than because it has any 
functional necessity.  However, an argument against this hypothesis is that very few of 
the many PG cells that were not directly surrounding glomeruli in the human OB were 
actually labeled with any of the PG marker probes, which are also indications of 
functionality.  In mice, over 80% of PG cells are labeled with any one or more of these 
probes (70).  Perhaps PG cells in the human are participatory but preferentially belong to 




cells that are either remnants of earlier synaptic circuits that no longer exist, or else they 
could be newer generated PG cells that never found a target synaptic circuit in which to 
integrate.  While the role of these cells is unclear, they are potentially another source of 
evidence of deviation from the organization of the OB as defined in rodents.   
  
Large numbers of glomeruli in the human OB suggest a difference in the way that 
OSN axons find their glomerular targets as compared to rodents. 
One of the most important principles of odor processing in the OB that has been 
well established in rodents is the idea of molecular specificity; that OSN axons entering 
the OB form homotypic axon bundles within the ONL with other axons from OSNs 
expressing identical ORs before penetrating into the OB into their target glomerulus.  
This is a fundamental principal that identifies glomeruli as functional units and allows for 
efficient modulation of sensory input at this very first level of odor processing.  However, 
this molecular specificity has not yet been confirmed in the human OB.  One simple way 
to begin to address this is to see whether the numerical relationship between ORs and 
glomeruli that the principle of molecular specificity establishes is maintained in humans.   
 Based on rodent models, it was predicted that the human OB would contain ~700 
glomeruli, twice the ~350 OR genes that have been predicted based on genomic mining 
studies.  However, counting the glomeruli from seven OBs demonstrated the actual 
number of glomeruli to range from 2975 to 9325, with an average of 5569.  By defining 
glomeruli by co-localization with NCAM and VGlut2, a synaptic marker that is specific 
to glomeruli, this study was able to more rigorously delineate glomeruli for counting and 




of glomeruli in the human OB (80).  This group looked at Nissl staining, and therefore 
relied on the PG cells to outline glomeruli.  As demonstrated here, PG cells are rarely 
arranged in circumferential densities around regularly sized and shaped glomeruli, which 
are often clustered together.  While the Meisami group found about 8000 glomeruli in 
young people, which falls within the range identified in this study, they also found a 
linear decline in glomeruli with age, with only about 2000 glomeruli in the oldest group.  
While we did not see any clear indication that there was a correlation between age and 
number of glomeruli, we did see qualitative differences between the OBs from older 
donors compared to younger donors, with more poorly defined laminar layers and larger 
variability in the shapes and distributions of glomeruli.  Therefore, the fewer number of 
glomeruli counted by Meisami et al. in this older group is likely a consequence of the 
decreased organization in the GL, making identification of glomeruli based on PG cells 
even more difficult. 
 Using a synaptic marker that is specific to glomeruli, VGlut2, is an unequivocal 
method of identification.  However, there were still many difficulties encountered during 
the counting process.  As can be seen from the images of the human (Figure 8), glomeruli 
are clustered together, often overlapping within one 50 µm slice.  This difficulty was 
made particularly complicated by the fact that glomeruli in human often have atypical 
shapes, unlike the almost universal spherical shape seen in rodents.  Therefore, with 
overlapping glomeruli with unusual shapes, it was often hard to define exact borders or to 
distinguish closely approximated glomeruli from one another.  In addition, the 
compartmentalization within glomeruli established earlier (Figure 5) is also seen with 




prominent compartmentalizations within a single glomerulus from multiple smaller 
clustered glomeruli more difficult.  Finally, using the Abercrombie extrapolation might 
have also introduced some small error into the final calculation.  This formula corrects 
for the idea that three-dimensional objects are often split between slices and would 
therefore be double-counted.  The calculation makes the assumption that the objects 
counted are spherical, which is demonstrated here to not be the case.  However, despite 
the variability amongst individual glomeruli that was encountered, the two dimensional 
diameter measurements did average out to very close to a circle in every OB.  Lastly, 
glomeruli were only counted in a total of seven human olfactory bulbs.  This is a very 
small n, and it is likely that the final numbers of glomeruli are not perfectly representative 
of the population; despite this, the entire range varies significantly from the predicted 
value, making it extremely unlikely for the principles of axon convergence and OB 
organization that have been defined in rodents to be identical in humans. 
Despite these minor difficulties, this was an extremely rigorous evaluation of the 
number of glomeruli with truly unexpected results.  Why are there so many glomeruli in 
the human?  Does this deviation in organization also imply that there has been a loss of 
molecular specificity within the human OB?  Not necessarily.  Perhaps in humans the 
anatomically based definition of a glomerulus is different, and there has been a 
fragmentation of the prototypical spherical glomeruli into smaller units.  The average 
glomerular size in humans is ~60 µm, smaller than the 85-100 µm in mice, despite having 
a larger OB.  Perhaps as the size of the glomerulus becomes larger with accumulating 
axonal inputs, there is a decrease in efficiency of regulation with the surrounding 




The occurrence of sometimes discrete clusters of glomeruli in humans is something that 
is not seen in rodents, where the glomeruli are almost linearly arranged around the OB.  
So perhaps what is a discrete sphere in a mouse, is, in humans, a cluster of glomerular 
units representing a single OR.  In this way, not only would there be preservation of 
homotypic convergence, but there could still be the numerically retained relationship 
between ORs and glomerular target areas, if there were about 700 of these clusters in the 
OB.  However, even if this were the case, the high variability in circumferential 
glomerular localization (Figure 9) makes the idea of odor maps that are conserved 
between individuals extremely unlikely. 
Another hypothesis addressing these high glomerular counts in which molecular 
specificity and organization is maintained is related to the potential emergence of 
frequent polymorphisms within human olfactory receptor genes.  Linardopoulou et al. 
(92) identified up to 5 amino acid differences in copies of the same OR gene from 
different individuals.  Therefore, because of the unique property of OR gene expression 
in which only one allele is expressed in any given OSN, polymorphisms in one allele of a 
certain OR would lead to two distinct cell populations within the group of OSNs that 
express that OR.  It has been additionally discovered that even small changes to the 
amino acid sequence of an OR can affect the targeting of axons to their glomerulus (93).  
Taken together, this evidence indicates that there may be distinct glomeruli representing 
two different versions of a single OR gene.  While the presence of polymorphisms alone 
is unlikely to account for the large numbers of glomeruli seen in human OBs if all other 




adds complexity to the human olfactory system and would indeed account for larger 
numbers of glomeruli than predicted.     
 Another potential explanation for the large number of glomeruli is that instead of 
each OSN axon that expresses any given OR targeting one of two possible glomeruli in 
the OB, there are many more potential glomerular targets.  In this hypothesis, while there 
is maintenance of molecular specificity in which all axons converging on a single 
glomerulus express the same OR, there is a loss in the organizational efficiency seen in 
rodent OBs.  For 350 human ORs, with about 5500 glomeruli, that would mean that there 
would be an average of 16 potential glomerular targets per OR.  Part of the elegance of 
the rodent model is that having only two glomeruli per OR efficiently organizes olfactory 
input in the central nervous system immediately at the first stage of processing.  
Therefore, by having so many glomeruli per OB, it can be perceived as a loss in 
efficiency at this level.  As glomeruli are considered functional units in the process of 
integrating sensory input, such a dispersion of input units would require compensation 
through more complex local organization in the PG cells and granule cells, or at higher 
levels in the cortex.  If this compensation does not occur in this model, it is possible that 
such a loss in OB odor map organization may play a role in the human’s relatively poor 
olfactory sense.   
 The final potential explanation for such a large number of glomeruli in the human 
OB is that odor processing through evolution has diverged so much from rodents that 
there is no longer molecular specificity to glomerular targets; axons entering any given 
glomerulus are no longer from OSNs that express the same OR.  With mixed input, all 




no longer be possible in humans.  For example it would be impossible for a glomerulus to 
enhance the signal-to-noise ratio if the input it was receiving was not homogeneous.  In 
this case it would certainly be necessary for sensory integration and odor processing to 
take place at higher centers, and it certainly implies a loss in efficiency, which would also 
explain humans’ decreased capacity for odor detection and discrimination. 
So which of these explanations is correct?  Immunohistochemical staining with 
antibodies to specific ORs would in fact discriminate between many of these hypotheses.  
As part of this study individual mOR antibodies were used to attempt to answer this 
question, however the staining was not successful in that it did not identify any glomeruli 
in the OB.  It is likely that the antibodies, which are specific to mouse OBs, were not 
specific enough to recognize the human OR proteins, or else the staining was localized in 
glomeruli that weren’t represented on any of the slices examined.  If a specific OR 
antibody was developed that successfully stained glomeruli, the results would be 
extremely informative.   Large clusters of fluorescent glomeruli would indicate the 
fragmentation of glomerular spheres into smaller units.  Many glomeruli stained 
throughout the bulb would indicate that there are more than two potential glomerular 
targets per OR.  Finally, staining of only a part of a glomerulus would indicate a loss of 
molecularly specific glomerular input. 
 
High variability in the number of glomeruli indicates that there are many factors 
that can affect the organization of the OB. 
 In addition to the high number of glomeruli counted in each OB, another mystery 




ranging from 2975 to 9325.  This is not seen in rodents, in which there is a stereotypical 
odor map including consistent numbers of glomeruli with specific localizations within the 
OB. What potential factors could be influencing the number of glomeruli?  Glomeruli are 
composed of synaptic units between OSNs and PG cells, both of which are regenerated 
throughout life, as well as projection neurons, the mitral and tufted cells, which are stable 
and not regenerated.  The sensory input comes in through the OSNs, without which the 
glomeruli would not exist.  Therefore, any significant loss of OSNs might disrupt the 
synapses and result in a loss of glomeruli.    
OSNs have their cell bodies in the olfactory epithelium (OE) in the back of the 
nose.  This location in the nose is efficient for detecting odors, however for the same 
reason it is a sensitive area of tissue that is environmentally exposed to many pathogens 
and toxins that are inhaled with the odorants.  While most people experience temporary 
olfactory dysfunction with minor upper respiratory infections, this is mostly due to the 
congestion in the nasal passages that is obstructive to sniffing, and normal olfactory 
function returns as soon as nasal congestion clears.  However, people with more 
significant sinus infections do experience post-infectious parosmia (94), likely related to 
a disruption OSN integrity and normal OSN replication.  In addition, patients who 
undergo chemotherapy or radiation therapy to the head or neck region also commonly 
experience parosmia, also likely due to the disruption of OSN replication.  It is even 
possible in these cases that replication of PG cell precursors is affected as well, which 
might affect central processing of smell, adding another source of disturbance to 




Based on these lines of clinical evidence, it is appears that disruption of OSNs 
leads to symptomatic variation in olfaction, however there is limited anatomical evidence 
of how these changes are manifest in the human OB.  There is MRI imaging evidence 
that patients with post-traumatic and post-infectious olfactory dysfunction have smaller 
OB volumes (79, 94) than controls.  While there was no significant relationship between 
OB size and number of glomeruli our study, this was one of the relationships in which 
there was a positive trend, suggesting that with larger power to the study this relationship 
may become significant.  At the molecular and cellular level, a single previous study 
attempted to look at the affect of cancer treatment, including chemotherapy and radiation 
therapy of the head and neck, on OSN regeneration and number of glomeruli in the 
human OB (95) in post-mortem donors.   They noticed qualitatively less regeneration 
based on GAP43 staining compared with controls, but did not note differences in 
glomerular numbers.   However, this evaluation of glomeruli was also qualitative, based 
on a rating scale, using cellular staining to identify the gloerular structures.  As 
demonstrated earlier, qualitative evaluations of glomeruli, especially when based on PG 
cell distribution, are unreliable predictors of actual glomerular quantifications.    
Interestingly, the donor with the fewest number of glomeruli in our study was a 
patient who had acute myelogenous leukemia who had undergone chemotherapy.  From 
the limited medical history that was available, it is unclear at what time point relative to 
death he underwent this regimen.  It is also unclear whether he had symptomatic 
olfactory dysfunction.  None of the donors had reported olfactory dysfunction, however 




and in fact most patients with olfactory dysfunction are unaware of their condition (89, 
96).    
So what potential variations could be playing a role in the differences between 
glomerular numbers for the other OBs evaluated in this study?  Based on the small 
number of OB specimens counted, there was no statistical significance between the 
numbers of glomeruli and gender of the donor, nor was there a correlation between 
number of glomeruli and age; however age was one of the comparisons that demonstrated 
a trend that could potentially be significant with greater power to the study.  It does make 
logical sense that the olfactory system of an elderly person would be more likely to have 
accumulated a lifetime of infectious and toxic exposures.  Age, therefore, can be seen as 
an indirect measure of these variables, which have been described earlier to likely play a 
role in OSN integrity and regeneration, and possibly affect the number of glomeruli in the 
OB.  None of the available medical history for the OB donors provided meaningful 
information regarding potential sources of OSN dysfunction that could lead to changes in 
the numbers of glomeruli through this predicted mechanism.  However, it is likely that 
potentially relevant aspects of these patients’ clinical histories were either unrecognized 
or unreported, so their absence certainly does not oppose this explanation.  The best way 
to explore this idea further would be to select OBs for evaluation from post-mortem 
donors who had documented olfactory dysfunction due to trauma, infection, or chemical 
exposures, as well as the OBs from normal controls with actual documentation of normal 
olfactory function, and to compare these groups with relation to glomerular number and 




Finally, as an attempt to study “normal” human OB architecture, only OBs that 
were from donors without neurodegenerative disorders were evaluated to prevent 
obscuring of the normal and cellular and synaptic organization.  There are documented 
changes in OB architecture from patients with neurodegenerative disease, and in fact 
most of the current studies of OB organization are currently focused around clinical 
interests in these diseases, including most prominently Alzheimer’s disease (AD) and 
Parkinson’s disease (PD).   In both AD and more prominently in PD, olfactory 
dysfunction is one of the earliest symptoms (97-100), and some have even proposed to 
use olfactory testing to screen for these diseases in susceptible patient groups before 
symptomatic onset (101).  In AD, neurofibrillary tangles and senile plaques are found in 
100% of the OBs of patients during post-mortem analysis (91), while in PD Lewy bodies 
are also found in 100% of patients OBs (102).  An interesting correlation would be to 
evaluate the OBs from donors with known AD and PD to see how the architectural 
changes affiliated with these diseases processes affect measures of olfactory processing 
evaluated in this study.        
  
So is there histologic evidence to explain a relatively inferior olfactory system? 
There are several measures used to describe the acuity of the olfactory system.  
One is odor threshold, or detection, another is odor identification, and the third is odor 
discrimination.  Based on genomic mining studies, it is already known that humans have 
only about one-third the number of OR genes as compared to mice.  With fewer ORs, it is 




other mammalian species, decreasing our ability to identify odors.  In addition, weaker 
odorant binding to the ORs that are expressed, as well as binding of individual odorants 
to fewer numbers of ORs, could result both in higher odor thresholds as well as poorer 
odor discrimination.  Therefore, simply looking at the genetics, humans already have a 
basis for olfactory inferiority in all measures. 
Within the central nervous system, odor identification occurs in the olfactory 
cortex; however in order to correctly identify an odor, the sensory information must be 
properly integrated within the OB before entering the LOT.  In addition, both odor 
threshold and odor discrimination are dependent upon local circuits within the OB.  All 
of these processes require coordination of input from the central nervous system, sensory 
input from OSNs, as well as local circuit feedback and regulation through the PG cells 
and granule cells.  Therefore, disruption of the cellular and synaptic organization in the 
OB would also detract from the human’s ability to detect, discriminate, and identify 
odors.  While this study was able to confirm many principles of local odor processing in 
the OB, it identified several differences between humans and rodents at this level that 
may in fact support the idea that central processing is in fact less efficient, differences 
therefore that might begin to explain our poor sense of olfaction.  Most importantly, 
through simple quantification of glomeruli, this study raises interesting and essential 
questions related to one of these most fundamental concepts of organization in the OB, 
the idea of homotypic axon convergence and molecular specificity in glomeruli.  In 
conclusion, this study is only a brief and initial step in analyzing the organization of the 
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